AsianFin -- UnitedHealth Group shares jumped more than 12% in premarket trading Friday after Warren Buffett’s Berkshire Hathaway revealed a new stake in the health insurer.
Berkshire owned 5.04 million UnitedHealth shares worth about $1.57 billion as of June 30, according to a U.S. Securities and Exchange Commission filing.
The investment comes as UnitedHealth’s stock has been under pressure from surging healthcare costs, a U.S. Department of Justice probe into its billing practices, a cyberattack, and the December shooting death of former top executive Brian Thompson. The shares have dropped nearly 46% this year, making it the worst performer on the Dow Jones Industrial Average.
Last month, UnitedHealth projected full-year adjusted earnings per share of at least $16, missing analysts’ already lowered expectations, while second-quarter results also fell short of Wall Street forecasts.
In premarket trading, the stock was last up 12.4% at $305.10.
Explore more exclusive insights at nextfin.ai.
Insights
What factors contributed to UnitedHealth's stock decline this year?
How does Berkshire Hathaway's investment in UnitedHealth reflect on the company's market position?
What are the implications of UnitedHealth's earnings projections for investors?
How have healthcare costs impacted UnitedHealth's performance?
What are the key challenges facing UnitedHealth in the current market?
What regulatory scrutiny is UnitedHealth currently facing from the U.S. Department of Justice?
How does the recent cyberattack affect UnitedHealth's reputation and operations?
What historical performance trends can be observed in UnitedHealth's stock?
How does UnitedHealth's stock performance compare to other companies in the Dow Jones Industrial Average?
What might be the long-term effects of Berkshire Hathaway's stake in UnitedHealth?
How do analysts perceive the future of UnitedHealth following this investment?
What impact does the loss of a top executive have on a company's stock performance?
What are the broader trends in the health insurance market that could affect UnitedHealth?
What strategies might UnitedHealth employ to recover from its current challenges?
How does the size of Berkshire Hathaway's stake influence market perception of UnitedHealth?
What lessons can investors learn from UnitedHealth's recent stock performance?
Are there any recent developments in healthcare policy that could affect UnitedHealth?
How do investor sentiments shift following major investments like Berkshire Hathaway's?
What are the risks associated with investing in companies like UnitedHealth under current conditions?
